February 25 – March 1, 2019
Naples Beach & Golf Hotel, Naples, FL

This seminar will provide a clinically relevant updated review of neurobiology and brain function. Areas of emphasis will be the psychopharmacologic of treatment of schizophrenia, bipolar disorder, depression, anxiety, substance abuse, addictions, sleep disorders, borderline personality and the treatment of children/adolescents and the geriatric patient. The latest advances in the psychopharmacologic treatment of children, adolescents, adult and geriatric patients will be presented. Early interventions, treatment of the acute psychosis and treatment of the recovering psychotic will be emphasized. The seminar will indentify strategies for treating bipolar patients who are treatment resistant. Approaches to treatment resistant depression including use of the ketamine will be underscored. The role of switch versus augmentation and combination strategies for treatment-resistant depression will be reviewed as well as best treatments for subtypes of major depression including atypical depression. The role of psychopharmacology in the treatment of generalized anxiety disorders, obsessive-compulsive symptoms, panic symptoms, traumatic syndromes and ADD will be highlighted. Throughout the course the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications will be underscored, as will the potential hazards/benefits of polypharmacy drug interactions.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Evaluate psychotropic drug treatment options with particular emphasis on recent advances and practical prescribing information;
  • Analyze the latest research in neuro biology and brain function;
  • Incorporate evidence-based approaches to treating acutely psychotic and recovering psychotic patients;
  • Implement treatment strategies for depressive and bipolar patients, including bipolar patients who are noncompliant or treatment resistant;
  • Determine when to implement medical switch versus augmentation strategies for treatment resistant depression;
  • Evaluate the use of ketamine with its benefits and hazards in treatment resistant depression;
  • Review latest findings about inflammation and stress as they apply to the treatment of depression and anxiety spectrum disorders;
  • Analyze the role of benzodiazepines and antidepressants in the treatment of generalized anxiety disorder obsessive symptoms, panic symptoms, traumatic syndromes;
  • Identify mechanisms of sleep disorders and their effective psychopharmacologic treatment;
  • Evaluate the mechanisms and treatment for alcohol and substance abuse disorders;
  • Determine the role of antidepressants in the life cycle of women;
  • Evaluate latest advances in child and adolescent psychopharmacology;
  • Update the clinical approach to problems in geriatric psychopharmacology with emphasis on newly emerging medication treatment.

Target Audience

The winter seminars are a series of seminars of interest to health professionals in the field of psychiatry, psychology, medicine, surgery, pediatrics, nursing, social work, and counseling.


Carl Salzman, MD will be teaching Monday through Thursday with Barbara Coffey, MD, MS teaching Friday morning from 9 am – 10:15 am and Carl Salzman, MD, teaching Friday morning from 10:30 am – 12:15 pm

Monday, February 25, 2019
9:00 am – 12:15 pm
An updated and clinically relevant review of neurobiology as it applies to the etiology and pathology of psychiatric illness, and psychotropic drug treatment effects; the neurobiology of attachment biology and treatment of schizophrenia disorders; the new generation of antipsychotic drugs; clinical aspects of treatment: use of typical and atypical neuroleptics; concept of early intervention and prevention. Q&A.
Tuesday, February 26, 2019
9:00 am – 12:15 pm
Biology and treatment of schizophrenia disorders: the new generation of antipsychotic drugs; clinical aspects of treatment: use of typical and atypical neuroleptics; concept of early intervention and prevention; dual diagnosis; treatment of bipolar disorders. Q&A.
Wednesday, February 27, 2019
9:00 am – 12:15 pm
Depression; Neurobiology of Depression; diagnostic heterogeneity; what constitutes response; value of tricyclics; SSRI’s in perspective; new antidepressants; combination and augmentation strategies; new approaches to the bipolar patient; ketamine risks and benefits in treatment resistant depression. Q&A.
Thursday, February 28, 2019
9:00 am – 12:15 pm
Anxiety, + panic, + OCD: Which drug, when to use; how much and for how long; rational benzodiazepine use; non-benzodiazepine strategies; use of hypnotics; PTSD. Q&A.
Friday, March 1, 2019
9:00 am – 12:15 pm
Diagnosis and pharmacological treatment of psychiatric disorders in children and adolescents including ADHD, affective and anxiety disorders, tic disorders, and psychotic disorders; geriatrics; antidepressants in life cycles of women; personality disorders, is there a role for psychopharmacology? dual diagnosis: alcohol/substance abuse and psychiatric disorders; psychodynamics of prescribing; diverse meaning of medications. Q&A.


CARL SALZMAN, MD is a Professor of Psychiatry, Harvard Medical School, Beth Israel Deaconess Medical Center. He has served as Chairman, American Psychiatric Association Benzodiazepine Task Force. He has been awarded the Elvin V. Semrad Award for Outstanding Teaching in Psychiatry at the Massachusetts Mental Health Center, Vestermark Award from the American Psychiatric Association for Outstanding Contribution to Psychiatric Education, Heinz E. Lehmann Award from the New York State Department of Mental Hygiene for his contribution to psychiatric research, Teacher of the Year Award from CME and Outstanding Psychiatrist of the Year for Education by the Massachusetts Psychiatric Society. He has also been on numerous editorial boards including The American Journal of Psychiatry. Dr. Salzman is author of over 300 publications and 7 books. His latest book is Clinical Geriatric Psychopharmacology, 4th edition.

BARBARA COFFEY, MD, MS is a Division Chief, Child and Adolescent Psychiatry, and a Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine. She is an Associate Editor of Advanced Pediatric Psychopharmacology. Dr. Coffey is a former Director of the Tics and Tourette’s Clinics at McLean and Massachusetts General Hospital, and former Director of Pediatric Psychopharmacology at McLean Hospital. She is an Associate Editor of Advanced Pediatric Psychopharmacology and Journal of Child and Adolescent Psychopharmacology.

Other Winter Seminar Courses
Psychopharmacology: A Master Class
Carl Salzman, MD

Exercise and Other Medical and Complementary Ground Breaking Techniques for the Treatment of ADHD, Addictions, Social Disorder, Pain, Anorexia, Sleep Disorders, Anxiety, and Mood Disorders
John Ratey, MD

Meditation for Everyday Living and Peak Performance for Mental Health,
Medical, and Surgical Practices

Daniel Brown, PhD, ABPH


Physicians: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Harvard Medical School designates this live activity for a maximum of 15.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). Information on the process of converting AMA PRA Category 1 Credits™ to ECMECs® can be found at:

Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, is approved by the American Psychological Association to offer Continuing education for psychologists. The Continuing Education Program at Beth Israel Deaconess Medical School, a major teaching hospital of Harvard Medical School, maintains responsibility for this program and its contents. The Week-long programs offers 15 CE credits.

Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School, is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEPTM solely is responsible for all aspects of the program. The winter seminar programs meet the criteria for 15 clock hours.

Social Workers: This program has been approved for 15 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Numbers for each course follows:

Exercise and Other Medical and Complementary Ground Breaking Techniques for the Treatment of ADHD, Addictions, Social Disorder, Pain, Anorexia, Sleep Disorders, Anxiety, and Mood Disorders: John Ratey, MD – D72367-3

Essential Psychopharmacology, 2019: From Neuroscience to Advances in Treatment: Carl Salzman, MD and Barbara Coffey, MD, MS – D72367-4

Meditation for Everyday Living and Peak Performance for Mental Health,
Medical, and Surgical Practices:
Daniel Brown, PhD, ABPH – D72367-5

State of New York Social Workers: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is recognized by the New York State Education Department’s State Board for Social Work as an Approved Provider of continuing education for licensed social workers. 15 contact hours have been approved for these programs.

Nurses: These continuing nursing education activity were approved by ANA Massachusetts, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

ABMS/ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies:

  • Patient care and Procedural skills
  • Medical knowledge
  • Practice-based learning and improvement
  • Interpersonal and communication skills
  • Professionalism


  Registration Fee
before 12/15/18*
Registration Fee
after 12/15/18*
Physician, Nurse Practitioner, and Allied Health Professionals
Additional weeks $750
$995 $1,075
Residents, Fellows in Training, and Full-time Students $695 $695

*Add processing fee (non-refundable) $10. Registration by credit card (VISA, MasterCard or American Express) or check can be made through Harvard Medical School’s secure online registration system for week 1 or week 2. Registration by check (draft on a United States bank), please make payable to Harvard Medical School. Telephone or fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration, you will receive an email confirmation. Be sure to include an email address that you check frequently. Your email address is used for critical information including registration confirmation, evaluation and certificate. All fees shown in USD.

All course participants will receive a link to a website where they can download the course materials. You can purchase a printed copy at the time of online registration for $35 for Drs. Ratey and Brown’s courses and $50.00 for both of Dr. Salzman’s courses. Please note we will not have hard copies of the syllabus available for purchase at the conference.

By phone 617-384-8600, Monday-Friday, 9 am to 5 pm (EST) or by email at:

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS's policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Refunds, less an administrative fee of $75, will be issued for all cancellations received two weeks prior to the start of the course. Refund requests must be received by email. No refund will be issued should cancellation occur less than two weeks prior. “No shows” are subject to the full course fee and no refunds will be issued once the conference has started.


Naples Beach & Golf Hotel
The Naples Beach Hotel & Golf Club is an exclusive AAA-four Diamond beach front hotel that is built on a rich tradition of hospitality that began in 1946. Owned and operated by the Watkins family, the Beach Club is Naples’ only beach front resort with a newly reopened spectacular Jack Nicklaus designed golf course on site as well as tennis, spa, and water recreation. The last few years over $50 million has been invested in the resort offering 317-newly remodeled accommodations; new beachside pool complex; retail shopping; restaurants/bars; complimentary Kids Club; and renovated greens & tees. Additional shopping and dining can be found in downtown Naples, just minutes away. The Naples Zoo, Botanical Gardens, and Everglades are other attractions within driving distance.

A limited number of rooms have been reserved at Naples Beach & Golf Hotel. For information and reservations, contact 1.800.237.7600 or the RESORT: Please advise them that you are with the Harvard Medical School Conference. Reservations must be made by January 19, 2019 to reserve a reduced room rate. Reservations made after that date are subject to availability. Please do not purchase non-refundable airline ticket(s) until you have received an email from our office confirming your paid registration.

Last update 9.2.2018